AARP Is Working to Help Older Adults Hit by Prescription Drug Shortages

We support federal fixes as shortages endanger access to vital medications

Miriam Cross,

Updated March 05, 2026

AARP

Comments

Published September 26, 2025

/ Updated March 05, 2026

AARP (Getty Images)

Older adults rely on prescription drugs more than any other age group. That means breakdowns in the drug supply chain and drug shortages have particularly challenging consequences for them.

A 2023 report from the U.S. Department of Health and Human Services found that nearly three-quarters of those impacted by drug shortages in the U.S. were between the ages of 45 and 85. 

The most common reason is manufacturing quality, according to the Food and Drug Administration. Scarcities also occur when natural disasters devastate a production plant, there are drastic changes in how drugs are used (such as with GLP-1s), manufacturers discontinue a product or raw materials experience production delays. 

“Shortages can happen for many reasons, from surging demand to supply disruptions, making it tough to pinpoint a single cause,” says Gidget Benitez, a government affairs director at AARP.

Join Our Fight to Lower Prescription Drug Costs

Here’s what you can do:

Tell lawmakers to protect older adults and taxpayers instead of big drug companies.
Find out more about how we’re fighting for you every day in Congress and across the country.
AARP is your fierce defender on the issues that matter to people 50-plus. Become a member or renew your membership today.

AARP is encouraging Congress to find holistic solutions to the problem that could help prevent such shortages in the future. We’ve fought for positive changes to ensure consumers have access to affordable medications, including the ability for Medicare to negotiate lower prices of some prescription drugs and an annual cap on out-of-pocket drug costs for Medicare Part D beneficiaries. But “persistent and worsening shortages of essential medicines underscore the growing instability of the drug supply chain and deep vulnerabilities that cannot be ignored,” AARP wrote in a statement for the record submitted to the U.S. House of Representatives Committee on Energy and Commerce Subcommittee on Health on Feb. 11.

A more restricted supply can cause drug prices to rise. But the steepest cost may be to health if patients are forced to stop taking a needed prescription or turn to other options because they can’t find the medicine they need. If people flock to an alternative medication because their first choice is depleted, the problem continues. Older Americans are particularly susceptible because they often rely on four to five medications per month.

Most Popular

AARP supports federal efforts and proposals that would prevent prescription drug shortages, including:

Stockpiling critical prescription drug ingredients 

President Trump signed an executive order on Aug. 13, 2025, detailing plans to reserve a six-month supply of the active pharmaceutical ingredients, or APIs, needed to make certain critical drugs, with a focus on domestic sourcing. 

The creation of this stockpile is important because “reduced access to needed prescription drugs — whether due to emergency circumstances, supply chain disruptions or other causes — can delay or deny critical care or force prescribers to turn to less effective alternatives,” Megan O’Reilly, vice president of health and family for government affairs at AARP, wrote in an Aug. 26 letter last to leaders at the U.S. Department of Health and Human Services. “We view this effort as one part of the more comprehensive changes that are needed for a sustainable solution.” 

Monitoring the supply chain 

On Sept. 16, 2025, AARP chief advocacy and engagement officer Nancy LeaMond sent letters to a bipartisan group of senators and representatives endorsing the Mapping America’s Pharmaceutical Supply, or MAPS, Act. The bill, which has been referred to committees in both the House and Senate, would require federal agencies to coordinate with the private sector and “map” the entire supply chain of certain essential medicines and identify vulnerabilities — in other words, to create a clear picture of the producers, manufacturers and other entities involved in manufacturing the drugs from start to finish.

“This information will play a crucial role in efforts to detect and prevent supply chain disruptions, helping to ensure that patients continue to have access to the medications they need,” LeaMond wrote.

Calling attention to the risks of a drug shortage 

AARP submitted a statement for the record on Sept. 17 last year to the U.S. Senate Special Committee on Aging, which organized a hearing about vulnerabilities in the drug supply chain and the challenges that drug shortages pose for older Americans. 

The statement stressed the importance of proactive measures such as an API stockpile, legislation mapping the drug supply chain and bipartisan work within the Senate Finance Committee to stabilize the supply of essential generic medicines. 

"For those managing health conditions, a stable and secure supply of medications is not just important, it is often life-sustaining," AARP wrote in the statement. "The federal government can play a vital role in proactively identifying risks and addressing weaknesses in the supply chain before they result in harmful shortages."

Affordable health care, including prescription drugs, remains a top concern for people age 50 and older. AARP’s February statement reinforces the connection between supply chain disruptions and drug prices, and that preventing shortfalls in the first place through bipartisan solutions is much more effective than trying to fix the problem after it has occurred. “AARP recognizes that drug shortages are driven by complex and multifaceted causes that will need broad, long-term solutions,” reads the statement, such as the executive order to stockpile key ingredients or the bipartisan MAPS Act mentioned above.